Últimas noticias sobre Getty Images Holdings (NYSE:GETY) Bolsa

Getty Images Holdings

Getty Images Holdings Inc is engaged in the core mission of bringing the world's creative and editorial visual content solutions to its customers to engage their audiences. the company has developed market enhancements across e-commerce, content subscriptions, user-generated content, diverse and inclusive content, and proprietary research alongside investment in its technology platform, which includes artificial intelligence and machine learning-driven search functionality and image editing and integrated APIs, to become a trusted industry leader in the visual content. Geographically the company operates in the Americas, Europe, the Middle East, Africa, and Asia-Pacific, out of which a majority of its revenue is generated from the Americas.

Medtronic, Fluor And 3 Stocks To Watch Heading Into Tuesday

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

GETY

SGMO

STNE

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este martes: IHS, HQY, GETY, SGMO y STNE.

5 acciones en el foco este martes: IHS, HQY, GETY, SGMO y STNE

CWCO

SAIC

Aquí tienes cinco acciones estadounidenses que podrían llamar la atención de los inversores este lunes: SAIC, GETY, CTM, CWCO y TSQ.

5 acciones en el foco este lunes: SAIC, GETY, CTM, CWCO y TSQ

Getty Images Holdings, Inc. Class A Common Stock

Getty Images Holdings Inc

The U.S. Food and Drug Administration granted on Tuesday Fast Track designation to Johnson &amp; Johnson&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>) investigational nipocalimab for moderate-to-severe <a href="https://www.benzinga.com/general/health-care" target="_blank" rel="noreferrer noopener">Sjögren&#8217;s disease (SjD)</a>.
Last year, FDA granted Breakthrough Therapy designation (BTD) for <a target="_blank" href="https://www.benzinga.com/pressreleases/25/03/n44374366/nipocalimab-the-first-and-only-investigational-treatment-to-be-granted-u-s-fda-breakthrough-therap" rel="noreferrer noopener">the investigational therapy</a>.
The Phase 2 DAHLIAS study, <a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4384625-1&amp;h=1495278526&amp;u=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Fnipocalimab-demonstrates-significant-clinical-improvement-in-disease-activity-and-igg-reduction-in-phase-2-sjogrens-disease-study&amp;a=results+of+which+were+presented+last+year" rel="noreferrer noopener">presented last year</a>, represented the first-ever positive results of an investigational FcRn blocker as a potential targeted therapy in SjD.&nbsp;
<a target="_blank" href="https://c212.net/c/link/?t=0&amp;l=en&amp;o=4384625-1&amp;h=1819366589&amp;u=https%3A%2F%2Fwww.jnj.com%2Fmedia-center%2Fpress-releases%2Flate-breaking-results-show-nipocalimab-significantly-improves-sjogrens-disease-activity-in-a-phase-2-study&amp;a=The+study" rel="noreferrer noopener">The study</a> achieved the primary endpoint in the 15 mg/kg Q2W nipocalimab group, showing a greater than 70% relative average improvement in systemic disease activity at Week 24 compared to placebo and IgG reductions of more than 77%.
Also Read: <a target="_blank" href="https://www.benzinga.com/general/biotech/25/03/44375773/cancer-focused-nanobiotix-adjusts-2-7-billion-johnson-johnson-agreement-to-strengthen-finances-and-relieve-funding-burden" rel="noreferrer noopener">Cancer-Focused Nanobiotix Adjusts $2.7 Billion Johnson &amp; Johnson Agreement To Strengthen Finances And Relieve Funding Burden</a>
Trends of improvement were similarly observed across multiple secondary endpoints. Safety and tolerability were consistent with other nipocalimab clinical studies.
Sjögren&#8217;s disease, also known as Sjögren&#8217;s syndrome, is&nbsp;a chronic autoimmune disorder that primarily affects the body&#8217;s exocrine glands (or moisture-producing glands), particularly those responsible for producing tears and saliva, leading to dry eyes and mouth.
Earlier this month, Johnson &amp; Johnson decided to discontinue the Phase 3 VENTURA development program evaluating aticaprant, a kappa opioid receptor (KOR) antagonist, as an adjunctive treatment for major depressive disorder (aMDD). The move follows insufficient efficacy in the target patient population. The data confirmed aticaprant is safe and well-tolerated, and no new safety <a href="https://www.benzinga.com/25/03/44190052/johnson-johnson-stops-late-stage-depression-study-over-insufficient-efficacy" target="_blank" rel="noreferrer noopener">signals were identified</a>.
In February, Sanofi SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) and Johnson &amp; Johnson discontinued the E.mbrace phase 3 study evaluating a vaccine candidate for extraintestinal pathogenic E. coli. The companies determined that the vaccine candidate was not sufficiently effective at preventing invasive E. coli disease (IED) <a href="https://www.benzinga.com/general/biotech/25/02/43692253/sanofi-johnson-johnson-partnered-vaccine-against-bacterial-sepsis-flunks-late-stage-study" target="_blank" rel="noreferrer noopener">compared to placebo</a>.
JNJ Price Action: Johnson &amp; Johnson stock is up 0.71% at $164 at publication Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44378262/tesla-rival-zeekr-to-provide-free-advanced-driver-assistance-tech-in-china-report" target="_blank" rel="noreferrer noopener">Tesla Rival Zeekr To Provide Free Advanced Driver-Assistance Tech In China: Report</a></li>
</ul>
Photo: Gorodenkoff via Shutterstock

Biotech

Large Cap

Health Care

General

FDA Grants Fast Track Review To Johnson & Johnson's Nipocalimab For Autoimmune Disorder That Affects Tears, Saliva

Investors with a lot of money to spend have taken a bullish stance on Reddit (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RDDT#NYSE">RDDT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with RDDT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 37 uncommon options trades for Reddit.
This isn't normal.
The overall sentiment of these big-money traders is split between 51% bullish and 35%, bearish.
Out of all of the special options we uncovered, 20 are puts, for a total amount of $2,831,782, and 17 are calls, for a total amount of $818,447.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $270.0 for Reddit over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
In today's trading context, the average open interest for options of Reddit stands at 1073.53, with a total volume reaching 10,062.00. The accompanying chart delineates the progression of both call and put option volume and open interest for high-value trades in Reddit, situated within the strike price corridor from $55.0 to $270.0, throughout the last 30 days.
<h3>Reddit Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314544_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$11.85</td>
<td>$11.45</td>
<td>$11.6</td>
<td>$90.00</td>
<td>$580.0K</td>
<td>791</td>
<td>156</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$10.6</td>
<td>$10.2</td>
<td>$10.36</td>
<td>$100.00</td>
<td>$414.4K</td>
<td>760</td>
<td>9</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$5.25</td>
<td>$5.2</td>
<td>$5.25</td>
<td>$70.00</td>
<td>$322.3K</td>
<td>1.5K</td>
<td>1.2K</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$10.3</td>
<td>$10.2</td>
<td>$10.2</td>
<td>$110.00</td>
<td>$255.0K</td>
<td>853</td>
<td>316</td>
</tr>
<tr>
<td>RDDT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$70.25</td>
<td>$68.5</td>
<td>$69.39</td>
<td>$180.00</td>
<td>$235.9K</td>
<td>368</td>
<td>34</td>
</tr>
</tbody>
</table>

<h3>About Reddit</h3>
Reddit Inc is engaged in providing internet content. The company provides online human connections to communities, endless conversation, sports, business, crypto, television, and others. It generates a majority of revenue through the sale of advertising on mobile applications and websites. Other revenue consists of revenue from content licensing, Reddit Premium subscriptions, and products within the user economy.
Having examined the options trading patterns of Reddit, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Reddit</h3>
<ul>
<li>With a trading volume of 6,648,803, the price of RDDT is down by -11.51%, reaching $111.11.</li>
<li>Current RSI values indicate that the stock is may be approaching oversold.</li>
<li>Next earnings report is scheduled for 68 days from now.</li>
</ul>
<h3>What Analysts Are Saying About Reddit</h3>
Over the past month, 3 industry analysts have shared their insights on this stock, proposing an average target price of $165.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Redburn Atlantic downgraded its action to Sell with a price target of $75. 
&#x2A; Maintaining their stance, an analyst from Piper Sandler continues to hold a Overweight rating for Reddit, targeting a price of $220. 
&#x2A; An analyst from Raymond James has decided to maintain their Strong Buy rating on Reddit, which currently sits at a price target of $200. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Reddit with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

RDDT

Behind the Scenes of Reddit's Latest Options Trends

Financial giants have made a conspicuous bullish move on Nike. Our analysis of options history for Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) revealed 22 unusual trades.
Delving into the details, we found 63% of traders were bullish, while 18% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $279,675, and 15 were calls, valued at $1,127,250.
<h3>What's The Price Target?</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $95.0 for Nike over the last 3 months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Nike's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Nike's substantial trades, within a strike price spectrum from $60.0 to $95.0 over the preceding 30 days.
<h3>Nike Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314539_0.png" alt="Options Call Chart" />
<h3>Significant Options Trades Detected:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$11.9</td>
<td>$11.45</td>
<td>$11.6</td>
<td>$75.00</td>
<td>$232.0K</td>
<td>176</td>
<td align="right">0</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$11.45</td>
<td>$11.0</td>
<td>$11.3</td>
<td>$75.00</td>
<td>$226.0K</td>
<td>176</td>
<td align="right">500</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/18/26</td>
<td>$13.1</td>
<td>$11.6</td>
<td>$11.6</td>
<td>$75.00</td>
<td>$116.0K</td>
<td>176</td>
<td align="right">300</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$11.55</td>
<td>$11.4</td>
<td>$11.48</td>
<td>$62.50</td>
<td>$114.8K</td>
<td>3</td>
<td align="right">101</td>
</tr>
<tr>
<td>NKE</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>03/21/25</td>
<td>$2.77</td>
<td>$2.45</td>
<td>$2.63</td>
<td>$75.00</td>
<td>$78.9K</td>
<td>14.5K</td>
<td align="right">306</td>
</tr>
</tbody>
</table>

<h3>About Nike</h3>
Nike is the largest athletic footwear and apparel brand in the world. Key categories include basketball, running, and football (soccer). Footwear generates about two thirds of its sales. Its brands include Nike, Jordan (premium athletic footwear and clothing), and Converse (casual footwear). Nike sells products worldwide through company-owned stores, franchised stores, and third-party retailers. The firm also operates e-commerce platforms in more than 40 countries. Nearly all its production is outsourced to contract manufacturers in more than 30 countries. Nike was founded in 1964 and is based in Beaverton, Oregon.
After a thorough review of the options trading surrounding Nike, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Nike's Current Market Status</h3>
<ul>
<li>With a trading volume of 3,175,372, the price of NKE is up by 0.26%, reaching $73.89.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 2 days from now.</li>
</ul>
<h3>What The Experts Say On Nike</h3>
5 market experts have recently issued ratings for this stock, with a consensus target price of $85.4.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Jefferies has elevated its stance to Buy, setting a new price target at $115. 
&#x2A; Consistent in their evaluation, an analyst from Morgan Stanley keeps a Equal-Weight rating on Nike with a target price of $72. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Nike, targeting a price of $80. 
&#x2A; An analyst from Needham persists with their Buy rating on Nike, maintaining a target price of $80. 
&#x2A; Maintaining their stance, an analyst from Telsey Advisory Group continues to hold a Market Perform rating for Nike, targeting a price of $80. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Nike options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

Unpacking the Latest Options Trading Trends in Nike

Deep-pocketed investors have adopted a bearish approach towards e.l.f. Beauty (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ELF#NYSE">ELF</a>), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ELF usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for e.l.f. Beauty. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 37% leaning bullish and 62% bearish. Among these notable options, 4 are puts, totaling $369,360, and 4 are calls, amounting to $204,723.
<h3>Predicted Price Range</h3>
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $65.0 to $80.0 for e.l.f. Beauty over the last 3 months. 
<h3>Volume &amp; Open Interest Trends</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for e.l.f. Beauty's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of e.l.f. Beauty's whale trades within a strike price range from $65.0 to $80.0 in the last 30 days. 
<h3>e.l.f. Beauty 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742314534_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.6</td>
<td>$15.55</td>
<td>$15.6</td>
<td>$70.00</td>
<td>$221.5K</td>
<td>1.0K</td>
<td align="right">193</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$15.95</td>
<td>$14.75</td>
<td>$14.75</td>
<td>$65.00</td>
<td>$88.5K</td>
<td>254</td>
<td align="right">0</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$15.6</td>
<td>$15.45</td>
<td>$15.6</td>
<td>$70.00</td>
<td>$78.0K</td>
<td>1.0K</td>
<td align="right">51</td>
</tr>
<tr>
<td>ELF</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/15/25</td>
<td>$9.0</td>
<td>$8.9</td>
<td>$9.0</td>
<td>$75.00</td>
<td>$59.4K</td>
<td>223</td>
<td align="right">86</td>
</tr>
<tr>
<td>ELF</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.45</td>
<td>$16.4</td>
<td>$16.4</td>
<td>$65.00</td>
<td>$40.9K</td>
<td>271</td>
<td align="right">25</td>
</tr>
</tbody>
</table>

<h3>About e.l.f. Beauty</h3>
e.l.f. Beauty Inc is a multi-brand beauty company that offers inclusive, accessible, clean, vegan and cruelty-free cosmetics and skin care products. The Company's mission is to make the best of beauty accessible to every eye, lip, face, and skin concern. The company offers cosmetic accessories for women which include eyeliner, mascara, false eyelashes, lipstick, the foundation for the face, moisturizer, cleanser, and other tools through its stores and e-commerce channels. The products that the company sells are marketed under the e.l.f. Cosmetics, W3LL PEOPLE and Keys Soulcare brands. It carries out sales within the US and internationally, out of which maximum revenue is generated from the US.
Following our analysis of the options activities associated with e.l.f. Beauty, we pivot to a closer look at the company's own performance.
<h3>Current Position of e.l.f. Beauty</h3>
<ul>
<li>With a trading volume of 856,543, the price of ELF is down by -4.81%, reaching $62.96.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 64 days from now.</li>
</ul>
<h3>Expert Opinions on e.l.f. Beauty</h3>
In the last month, 3 experts released ratings on this stock with an average target price of $93.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from DA Davidson has decided to maintain their Neutral rating on e.l.f. Beauty, which currently sits at a price target of $80. 
&#x2A; Maintaining their stance, an analyst from DA Davidson continues to hold a Neutral rating for e.l.f. Beauty, targeting a price of $75. 
&#x2A; Maintaining their stance, an analyst from Goldman Sachs continues to hold a Buy rating for e.l.f. Beauty, targeting a price of $124. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for e.l.f. Beauty, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

e.l.f. Beauty's Options Frenzy: What You Need to Know

Hesai Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HSAI#NASDAQ">HSAI</a>) stock is under pressure Tuesday after short seller Blue Orca Capital targeted the company in a new report alleging Hesai Group is actively <a href="https://www.benzinga.com/quote/HSAI">lying to investors</a>.
What To Know: Blue Orca Capital released a short report on Tuesday, calling Hesai group a &#8220;Chinese scam.&#8221; The short seller believes the company is lying by insisting it has no involvement with the Chinese military. Blue Orca also raised concerns around the company&#8217;s financial disclosures.
&#8220;In short, we think Hesai is full of lies, from its suspect financials to its denials made to the government and in court regarding its LiDAR and the Chinese military. In our opinion, it is completely untrustworthy as a business and uninvestable as a stock,&#8221; the short seller said.
Benzinga has reached out to Hesai Group for comment on the report. 
Blue Orca alleged that Hesai has lied to investors and U.S. authorities about the use of its lidar technology for military purposes. The short seller provided images that it uncovered from Chinese government owned CCTV that appears to show a Chinese military vehicle equipped with a Hesai lidar system. 
The Department of Defense (DOD) placed Hesai Group on a list of companies designated as &#8220;Chinese military companies&#8221; in January 2024. Hesai sued the DOD in an attempt to be removed from the list. The short seller believes Hesai will lose the case and in turn become effectively blocked from any lucrative deals in the U.S. autonomous vehicles market.
&#8220;As such, we believe that Hesai will soon lose a customer cohort which historically accounted for 40% of its revenues and an estimated 57% of its gross profit,&#8221; the short seller said.
Check This Out: <a href="https://www.benzinga.com/general/sports/25/03/44379231/warren-buffett-2025-march-madness-challenge-winner-no-longer-has-to-be-perfect-i-want-to-give-away-a-million-dollars">Warren Buffett 2025 March Madness Challenge Winner No Longer Has To Be Perfect: &#8216;I Want To Give Away A Million Dollars&#8217;</a>
Blue Orca also noted that Hesai Group shares surged late last year after the company reported that it became profitable. The short seller believes the profitability was a result of a $20 million break-up fee from its largest customer that was undisclosed to investors. Blue Orca also indicated that the company appears to be laying off up to 30% of its workforce. 
Hesai Group shares surged again last week after the company secured a multi-year deal with&nbsp;Mercedes-Benz&nbsp;to&nbsp;<a href="https://www.benzinga.com/pressreleases/25/03/n44237694/hesai-selected-by-top-european-oem-for-exclusive-multi-year-lidar-contract-on-its-next-generation-" target="_blank" rel="noreferrer noopener">supply lidar sensors</a>, closing the day up more than 50%. The short seller poked holes in the notion that the deal is &#8220;exclusive.&#8221; Blue Orca is also skeptical given that Mercedes was unwilling to publicly confirm the deal. The short seller noted that Hesai Group founders sold $68.6 million of stock following the spike.
Blue Orca went on to raise concerns about inconsistent purchasing volumes with reported sales, &#8220;inexplicable&#8221; margin expansion and the withdrawal of the company&#8217;s IPO in China. 
&#8220;Ultimately, we do not think that U.S. authorities will permit a Chinese military company whose products are equipped on Chinese military vehicles to take advantage of the privilege of American capital markets,&#8221; the short seller said.
HSAI Price Action: Hesai Group shares are up nearly 300% over the past year. The stock was down 8.5% at $20.39 at the time of publication Tuesday, according to <a href="http://pro.benzinga.com">Benzinga Pro</a>.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/economics/macro-economic-events/25/03/44379453/equity-exposure-plummets-cash-holdings-jump-as-investors-rethink-us-exceptionalism-bank-of-america-survey">Equity Exposure Plummets, Cash Holdings Jump As Investors Rethink &#8216;US Exceptionalism,&#8217; Bank Of America Survey</a></li>
</ul>
Photo: Shutterstock.

Asia

Short Sellers

Short Ideas

HSAI

Short Seller Says Hesai Group Stock Is A 'Chinese Scam'

The Trump administration granted Nippon Steel and United States Steel Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>) a 21-day extension in their lawsuit over the proposed merger, <a href="https://www.benzinga.com/25/02/43576917/trump-says-reconsiders-nippon-steels-149-billion-us-steel-deal-theyve-agreed-to-invest-heavilyas-opposed-to-own-it" target="_blank" rel="noreferrer noopener">allowing further negotiations with regulators.</a>
What Happened: The Wall Street Journal <a href="https://www.wsj.com/business/deals/nippon-steel-u-s-steel-lawsuit-gets-extension-to-continue-government-negotiations-3638d994" target="_blank" rel="noreferrer noopener">reported </a>that the Department of Justice pushed back the litigation briefing deadlines, citing a motion filed on Friday. 
Additionally, the oral argument, initially set for April 24, has been rescheduled to May 12.
The move indicates that President Donald Trump may approve the deal, <a href="https://edition.cnn.com/2025/03/17/business/us-steel-nippon-trump-cfius/index.html" target="_blank" rel="noreferrer noopener">reports </a>CNN.
Former President Joe Biden <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42787508/biden-blocks-14-9b-us-steel-takeover-shares-plunge">blocked it</a>, citing national security and domestic supply chain concerns.
Also Read:<a target="_blank" href="https://www.benzinga.com/tech/25/03/44376743/google-parent-alphabet-to-acquire-wiz-in-32-billion-deal-its-biggest-bet-yet" rel="noreferrer noopener"> Google Parent Alphabet To Acquire Wiz In $32 Billion Deal, Its Biggest Bet Yet</a>
Why It Matters: Last month, Trump contemplated approving Nippon Steel&#8217;s $14.1<a href="https://www.benzinga.com/markets/asia/25/02/43574248/trump-hints-at-rekindling-nippon-steels-14-billion-acquisition-of-united-steel-in-talks-with-japanese-pm-ishiba" target="_blank" rel="noreferrer noopener"> billion bid</a> for U.S. Steel as an investment rather than a purchase. The remarks were made in the presence of Japanese Prime Minister Shigeru Ishiba at the Oval Office.
The latest extension aims to facilitate continued discussions between the companies and the government in an attempt to resolve the situation without proceeding to a full legal resolution.
In December 2023, Nippon Steel agreed to purchase U.S. Steel, but ended up in a legal dispute with the Biden administration last year over the stalled acquisition.
In early January, CEO&nbsp;Eiji Hashimoto&nbsp;<a target="_blank" href="https://www.benzinga.com/markets/25/01/42870745/nippon-steel-ceo-slams-tariffs-defends-15-billion-us-steel-merger-amid-national-security-concerns-we-never-think-that-industry-can-become-stronger-through-tariffs-alone" rel="noreferrer noopener">dismissed tariffs as an inadequate solution</a>&nbsp;for bolstering the U.S. steel industry. He defended the merger, asserting that it would strengthen national security by creating a more resilient and competitive company.
In response, Nippon Steel and U.S. Steel filed a lawsuit in January, claiming the decision was influenced by President Biden&#8217;s desire to gain favor with the United Steelworkers union in Pennsylvania.
According to&nbsp;<a target="_blank" href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw" rel="noreferrer noopener">Benzinga Pro</a>, X stock has gained over 3% in the past year. Investors can gain exposure to the stock via&nbsp;SPDR S&amp;P Metals &amp; Mining ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XME#NYSE">XME</a>).
Price Action: X shares are trading higher by 0.36% to $40.26 premarket at last check Tuesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/25/03/44377660/walgreens-executive-chair-stefano-pessina-seeks-to-strengthen-control-with-nearly-double-stake" target="_blank" rel="noreferrer noopener">Walgreens&#8217; Executive Chair Stefano Pessina Seeks To Strengthen Control With Nearly Double Stake</a></li>
</ul>

Equities

Politics

Movers

Trump Eyes Approval Of Controversial Steel Merger: Nippon, US Steel Await Key Decision

Today at Adobe Summit – the flagship digital experience conference – Adobe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADBE#NASDAQ">ADBE</a>) announced a strategic collaboration with Amazon Web Services (AWS) to build new offerings that empower marketing and creative teams to deliver customer experiences with greater speed, precision and at scale. The collaboration combines Adobe's expertise in Customer Experience Orchestration with AWS's advanced cloud services.
Building on the <a href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fprotect.checkpoint.com%2Fv2%2F___https%3A%2Fnews.adobe.com%2Fnews%2F2024%2F12%2F120324-adobe-and-amazon-web-services-partner-to-bring-adobe-experience-platform-to-brands-and-enhance-customer-engagement-with-deep-insights___.YzJ1OndlY29tbXVuaWNhdGlvbnM6YzpvOmEyYmFiNGYyN2VmMmM3YmUzOWUyMzQ4ZTRlNzIwMGUwOjY6MDMzNjo5OTE5Y2JhYzg1ZTY4YjRjNzRlN2RiYmJmOTAzYmY4YmU5Mjg3MWQ2YjkzMzNhMTY1OWYyMmNmNDRjNzQ3YjVmOnA6RjpG&amp;esheet=54225569&amp;newsitemid=20250318724273&amp;lan=en-US&amp;anchor=availability&amp;index=1&amp;md5=922b61f87b0d114ded9ebdbef96afe8b">availability</a> of Adobe Experience Platform (AEP) on AWS, the collaboration will introduce new integrations with AWS's generative AI services, Amazon Connect and Amazon Ads. These offerings will enable organizations to create more meaningful customer interactions while benefiting from AWS's enterprise-grade security, reliability and global infrastructure.

ADBE

AMZN

Adobe And AWS Announced Strategic Collaboration To Enhance Customer Experience Orchestration With New Integrations, Including Generative AI Services, Amazon Connect, And Amazon Ads

Morgan Stanley analyst Hamza Fodderwala maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Equal-Weight and lowers the price target from $47 to $40.

Price Target

Analyst Ratings

TENB

Morgan Stanley Maintains Equal-Weight on Tenable Holdings, Lowers Price Target to $40

Macro Economic Events

Contracts

Global

Economics

ORCL

Oracle Weighs Security Role, Small Stake To Land TikTok Deal; Oracle Would Offer Security Guarantee If China Keeps Algorithm

Morgan Stanley analyst Hamza Fodderwala maintains SentinelOne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/S#NYSE">S</a>) with a Equal-Weight and lowers the price target from $27 to $20.

Morgan Stanley Maintains Equal-Weight on SentinelOne, Lowers Price Target to $20

SoundHound AI, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SOUN#NASDAQ">SOUN</a>) is presenting its conversational AI voice technology this week at the 2025 NVIDIA GPU Technology Conference (GTC) in <a href="https://www.benzinga.com/trading-ideas/long-ideas/25/03/44360400/legendary-trader-says-tesla-nvidia-apple-shares-are-ready-to-rally-i-see-what-i-like-to-see">San Jose, California.&nbsp;</a>
What To Know: SoundHound <a href="https://www.benzinga.com/25/03/44336786/whats-going-on-with-soundhound-ai-stock-friday">will showcase</a> several AI voice technology products, including its next-generation in-vehicle voice assistant, which integrates generative AI with NVIDIA Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>)'s DRIVE AGX platform.&nbsp;
Read Next: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/03/44367584/black-swan-hedge-fund-posts-4000-profits-during-covid-19-market-crash-heres-how">&#8216;Black Swan&#8217; Hedge Fund Posts 4,000% Profits During COVID-19 Market Crash: Here&#8217;s How</a>
The company will also demo its in-car voice commerce ecosystem that enables drivers to make hands-free, voice-controlled orders and purchases ordering and purchasing from their vehicle.&nbsp;
SoundHound mentioned both of the above technologies in <a href="https://x.com/SoundHound/status/1901668331125432345">a post</a> on social media and called its&nbsp; in-car voice commerce ecosystem "a game-changer for #AutomotiveTech."
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">&#x1f697;&#x1f4a1; This week, we're live from NVIDIA <a href="https://twitter.com/hashtag/GTC2025?src=hash&amp;ref_src=twsrc%5Etfw">#GTC2025</a>! Stop by booth 1842 to experience SoundHound Chat AI Automotive, our award-winning voice assistant leveraging <a href="https://twitter.com/hashtag/GenerativeAI?src=hash&amp;ref_src=twsrc%5Etfw">#GenerativeAI</a> on the edge with NVIDIA DRIVE AGX. Plus, check out our in-car voice commerce ecosystem, allowing drivers… <a href="https://t.co/OCM0xe8De4">pic.twitter.com/OCM0xe8De4</a>
&mdash; SoundHound AI (@SoundHound) <a href="https://twitter.com/SoundHound/status/1901668331125432345?ref_src=twsrc%5Etfw">March 17, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Additionally, SoundHound's AI-powered drive-thru food ordering system powered by Oracle Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>) Cloud Infrastructure will be featured at Oracle's GTC booth as well.&nbsp;
SoundHound AI senior vice president Ben Bellettini recently described the company's business segments as a three-pilar design in an<a href="https://foodondemand.com/03112025/soundhound-ai-rolls-out-new-voice-features-and-bets-big-on-cars/"> interview</a> with Food On Demand.&nbsp;
"We see cars as the tip of the spear," he said, referring to SoundHound's in-vehicle voice assistant technology.&nbsp;
"Supporting automakers is a core pillar for us. A second pillar is providing voice solutions for restaurants. Our third pillar is wedding those two together."
SOUN Price Action: According to data from <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, SoundHound AI shares were down 3.27% at $9.75 amid a broad market sell-off at the time of publication Tuesday.&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/travel/25/03/44359238/severe-storm-system-brings-devastation-at-least-42-dead-power-outages-widespread-damage-reported">Severe Storm System Brings Devastation: At Least 42 Dead, Power Outages, Widespread Damage Reported&nbsp;</a></li>
</ul>
Photos: Shutterstock

Events

Tech

NVDA

SOUN

SoundHound AI At 2025 NVIDIA GPU Technology Conference: In-Car Voice Commerce Ecosystem 'A Game-Changer For #AutomotiveTech'

Morgan Stanley analyst Erin Wilson maintains Rapid7 (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RPD#NASDAQ">RPD</a>) with a Equal-Weight and lowers the price target from $38 to $33.

Morgan Stanley Maintains Equal-Weight on Rapid7, Lowers Price Target to $33

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul>
<li>Barclays analyst Lauren Lieberman downgraded the rating for PepsiCo, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEP#NASDAQ">PEP</a>) from Overweight to Equal-Weight and lowered the price target from $168 to $156. PepsiCo shares closed at $151.34 on Monday. <a href="https://www.benzinga.com/quote/pep/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Guggenheim analyst Michael Schmidt downgraded Incyte Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) from Buy to Neutral and maintained the price target of $92. Incyte shares closed at $62.01 on Monday. <a href="https://www.benzinga.com/quote/INCY/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Jefferies analyst Julien Dumoulin-Smith downgraded TPI Composites, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TPIC#NASDAQ">TPIC</a>) from Hold to Underperform and lowered the price target from $2.3 to $0.5. TPI Composites shares closed at $1.20 on Monday. <a href="https://www.benzinga.com/quote/TPIC/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>UBS analyst Steven Fisher downgraded PACCAR Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PCAR#NASDAQ">PCAR</a>) from Buy to Neutral and announced a $108 price target. PACCAR shares closed at $101.17 on Monday. <a href="https://www.benzinga.com/quote/PCAR/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>William Blair analyst Y Katherine Xu downgraded the rating for Incyte (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INCY#NASDAQ">INCY</a>) from Outperform to Market Perform. Incyte shares closed at $62.01 on Monday.  <a href="https://www.benzinga.com/quote/ONCY/analyst-ratings">See how other analysts view this stock.</a></li>
</ul>
Considering buying PEP stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-1024x571.png" alt="" class="wp-image-829930" style="width:592px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/03/18120202/image-151.png 1135w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/03/44355158/jim-cramer-says-this-tech-stock-is-a-meme-stock-recommends-buying-accenture">Jim Cramer Calls This Stock A &#8216;Meme Stock,&#8217; Recommends Buying Accenture</a></li>
</ul>

Downgrades

INCY

PCAR

TPIC

This PepsiCo Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

Morgan Stanley analyst Ronald Kamdem maintains Paramount Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGRE#NYSE">PGRE</a>) with a Equal-Weight and lowers the price target from $4.25 to $4.

PGRE

Morgan Stanley Maintains Equal-Weight on Paramount Group, Lowers Price Target to $4

Jaguar Health Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JAGX#NASDAQ">JAGX</a>) shares are trading lower by 40.1% to 28 cents during Tuesday&#8217;s session after the company announced a <a href="https://www.benzinga.com/pressreleases/25/03/ac44375204/jaguar-health-inc-announces-reverse-stock-split">1-for-25 reverse stock split</a> of its common stock, set to take effect on March 24, to maintain compliance with Nasdaq listing requirements.
The stock will trade on a split-adjusted basis under the same ticker. CEO Lisa Conte stated the move aims to attract institutional investors by adjusting the share price and count. 
Approved by stockholders at a Special Meeting, the split will convert every 25 shares into one without changing par value. 
No fractional shares will be issued, and stockholders will receive cash for fractions. Equiniti Trust Company, LLC will manage the exchange, with brokerage account holders requiring no action.
Read Also: <a href="https://www.benzinga.com/trading-ideas/technicals/25/03/44378861/stock-of-the-day-does-classic-pattern-in-microsoft-mean-a-move-higher">Stock Of The Day – Does Classic Pattern In Microsoft Mean A Move Higher?</a>
<h2 class="wp-block-heading">Is JAGX A Good Stock To Buy?</h2>
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages &#8211; like <a href="https://www.benzinga.com/quote/JAGX">Jaguar Health</a>&#8216;s page for example &#8211; there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on <a href="https://www.benzinga.com/quote/JAGX">Jaguar Health</a> will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
According to data from&nbsp;<a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>, JAGX has a 52-week high of $21.60 and a 52-week low of $0.32.

JAGX

Why Jaguar Health (JAGX) Stock Is Trading Lower

RTX (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RTX#NYSE">RTX</a>) has outperformed the market over the past 5 years by 2.68% on an annualized basis producing an average annual return of 22.92%. Currently, RTX has a market capitalization of $176.06 billion. 
Buying $1000 In RTX: If an investor had bought $1000 of RTX stock 5 years ago, it would be worth $2,548.67 today based on a price of $131.87 for RTX at the time of writing.
<h3>RTX's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742313654_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning RTX Stock In The Last 5 Years

Investors with a lot of money to spend have taken a bearish stance on Arista Networks (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ANET#NYSE">ANET</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ANET, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 17 uncommon options trades for Arista Networks.
This isn't normal.
The overall sentiment of these big-money traders is split between 35% bullish and 47%, bearish.
Out of all of the special options we uncovered, 9 are puts, for a total amount of $972,160, and 8 are calls, for a total amount of $656,220.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $70.0 and $122.5 for Arista Networks, spanning the last three months.
<h3>Volume &amp; Open Interest Trends</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Arista Networks's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Arista Networks's substantial trades, within a strike price spectrum from $70.0 to $122.5 over the preceding 30 days.
<h3>Arista Networks 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742313645_0.png" alt="Options Call Chart" />
<h3>Biggest Options Spotted:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$16.8</td>
<td>$16.6</td>
<td>$16.64</td>
<td>$90.00</td>
<td>$415.2K</td>
<td>733</td>
<td>254</td>
</tr>
<tr>
<td>ANET</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/16/25</td>
<td>$18.1</td>
<td>$18.0</td>
<td>$18.0</td>
<td>$100.00</td>
<td>$235.8K</td>
<td>1.1K</td>
<td>150</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>04/17/25</td>
<td>$11.0</td>
<td>$10.5</td>
<td>$10.5</td>
<td>$75.00</td>
<td>$210.0K</td>
<td>487</td>
<td>200</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$0.8</td>
<td>$0.7</td>
<td>$0.7</td>
<td>$122.50</td>
<td>$140.0K</td>
<td>5.0K</td>
<td>1.9K</td>
</tr>
<tr>
<td>ANET</td>
<td>CALL</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>01/16/26</td>
<td>$18.2</td>
<td>$17.9</td>
<td>$18.03</td>
<td>$80.00</td>
<td>$90.1K</td>
<td>1.4K</td>
<td>52</td>
</tr>
</tbody>
</table>

<h3>About Arista Networks</h3>
Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.
Having examined the options trading patterns of Arista Networks, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Arista Networks</h3>
<ul>
<li>Currently trading with a volume of 3,380,910, the ANET's price is down by -1.36%, now at $83.93. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 49 days.</li>
</ul>
<h3>Expert Opinions on Arista Networks</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $119.8.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Maintaining their stance, an analyst from UBS continues to hold a Neutral rating for Arista Networks, targeting a price of $112. 
&#x2A; Consistent in their evaluation, an analyst from Wells Fargo keeps a Overweight rating on Arista Networks with a target price of $125. 
&#x2A; An analyst from Barclays persists with their Overweight rating on Arista Networks, maintaining a target price of $126. 
&#x2A; An analyst from Citigroup has decided to maintain their Buy rating on Arista Networks, which currently sits at a price target of $121. 
&#x2A; In a positive move, an analyst from UBS has upgraded their rating to Buy and adjusted the price target to $115. 
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Arista Networks options trades with real-time alerts from <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.

ANET

Arista Networks's Options Frenzy: What You Need to Know

Financial giants have made a conspicuous bearish move on Taiwan Semiconductor. Our analysis of options history for Taiwan Semiconductor (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>) revealed 65 unusual trades.
Delving into the details, we found 27% of traders were bullish, while 61% showed bearish tendencies. Out of all the trades we spotted, 30 were puts, with a value of $3,476,335, and 35 were calls, valued at $4,896,222.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $110.0 to $220.0 for Taiwan Semiconductor over the recent three months. 
<h3>Insights into Volume &amp; Open Interest</h3>
Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Taiwan Semiconductor's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Taiwan Semiconductor's whale trades within a strike price range from $110.0 to $220.0 in the last 30 days. 
<h3>Taiwan Semiconductor 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742313640_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSM</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>05/16/25</td>
<td>$13.2</td>
<td>$13.05</td>
<td>$13.05</td>
<td>$170.00</td>
<td>$2.6M</td>
<td>6.8K</td>
<td>2.0K</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$10.0</td>
<td>$9.95</td>
<td>$9.95</td>
<td>$165.00</td>
<td>$888.5K</td>
<td>6.3K</td>
<td>953</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$9.45</td>
<td>$9.3</td>
<td>$9.45</td>
<td>$140.00</td>
<td>$567.0K</td>
<td>4.6K</td>
<td>1.0K</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$8.95</td>
<td>$8.8</td>
<td>$8.9</td>
<td>$150.00</td>
<td>$150.4K</td>
<td>9.2K</td>
<td>569</td>
</tr>
<tr>
<td>TSM</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$6.6</td>
<td>$6.45</td>
<td>$6.55</td>
<td>$155.00</td>
<td>$142.1K</td>
<td>3.5K</td>
<td>720</td>
</tr>
</tbody>
</table>

<h3>About Taiwan Semiconductor</h3>
Taiwan Semiconductor Manufacturing Co. is the world's largest dedicated chip foundry, with over 60% market share. TSMC was founded in 1987 as a joint venture of Philips, the government of Taiwan, and private investors. It went public as an ADR in the US in 1997. TSMC's scale and high-quality technology allow the firm to generate solid operating margins, even in the highly competitive foundry business. Furthermore, the shift to the fabless business model has created tailwinds for TSMC. The foundry leader has an illustrious customer base, including Apple, AMD, and Nvidia, that looks to apply cutting-edge process technologies to its semiconductor designs. TSMC employs more than 73,000 people.
<h3>Taiwan Semiconductor's Current Market Status</h3>
<ul>
<li>Trading volume stands at 4,802,447, with TSM's price down by -1.87%, positioned at $172.27.</li>
<li>RSI indicators show the stock to be may be approaching oversold.</li>
<li>Earnings announcement expected in 30 days.</li>
</ul>
<h3>Professional Analyst Ratings for Taiwan Semiconductor</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $225.0.
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Needham downgraded its rating to Buy, setting a price target of $225. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Taiwan Semiconductor, <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> gives you real-time options trades alerts.

Check Out What Whales Are Doing With TSM

Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABT#NYSE">ABT</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with ABT, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 10 uncommon options trades for Abbott Laboratories.
This isn't normal.
The overall sentiment of these big-money traders is split between 30% bullish and 60%, bearish.
Out of all of the special options we uncovered, 2 are puts, for a total amount of $305,520, and 8 are calls, for a total amount of $280,024.
<h3>Predicted Price Range</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $75.0 to $135.0 for Abbott Laboratories over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Abbott Laboratories's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Abbott Laboratories's substantial trades, within a strike price spectrum from $75.0 to $135.0 over the preceding 30 days.
<h3>Abbott Laboratories Option Activity Analysis: Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1742313635_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ABT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$13.9</td>
<td>$13.4</td>
<td>$13.4</td>
<td>$130.00</td>
<td>$245.2K</td>
<td align="right">8</td>
<td align="right">228</td>
</tr>
<tr>
<td>ABT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/18/26</td>
<td>$14.25</td>
<td>$13.4</td>
<td>$13.4</td>
<td>$130.00</td>
<td>$60.3K</td>
<td align="right">8</td>
<td align="right">45</td>
</tr>
<tr>
<td>ABT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>09/19/25</td>
<td>$5.75</td>
<td>$5.65</td>
<td>$5.65</td>
<td>$135.00</td>
<td>$47.4K</td>
<td align="right">456</td>
<td align="right">325</td>
</tr>
<tr>
<td>ABT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.9</td>
<td>$4.85</td>
<td>$4.9</td>
<td>$135.00</td>
<td>$39.2K</td>
<td align="right">507</td>
<td align="right">174</td>
</tr>
<tr>
<td>ABT</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$4.85</td>
<td>$4.8</td>
<td>$4.8</td>
<td>$135.00</td>
<td>$36.9K</td>
<td align="right">507</td>
<td align="right">352</td>
</tr>
</tbody>
</table>

<h3>About Abbott Laboratories</h3>
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
Having examined the options trading patterns of Abbott Laboratories, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Current Position of Abbott Laboratories</h3>
<ul>
<li>Trading volume stands at 2,698,821, with ABT's price down by -1.06%, positioned at $126.28.</li>
<li>RSI indicators show the stock to be is currently neutral between overbought and oversold.</li>
<li>Earnings announcement expected in 29 days.</li>
</ul>
<h3>Professional Analyst Ratings for Abbott Laboratories</h3>
3 market experts have recently issued ratings for this stock, with a consensus target price of $154.67.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Abbott Laboratories, which currently sits at a price target of $154. 
&#x2A; An analyst from Citigroup persists with their Buy rating on Abbott Laboratories, maintaining a target price of $160. 
&#x2A; An analyst from B of A Securities has decided to maintain their Buy rating on Abbott Laboratories, which currently sits at a price target of $150. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Abbott Laboratories with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Decoding Abbott Laboratories's Options Activity: What's the Big Picture?

Morgan Stanley analyst Simeon Gutman maintains Okta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OKTA#NASDAQ">OKTA</a>) with a Overweight and raises the price target from $106 to $125.

OKTA

Morgan Stanley Maintains Overweight on Okta, Raises Price Target to $125

Legal

Press Releases

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, NARI, SSY on Behalf of Shareholders

Kuehn Law Encourages VINC, NEUE, GETY, and CLBR Investors to Contact Law Firm

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates GETY, CLBR, VINC, NEUE on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TURN, DFS, GETY on Behalf of Shareholders

Getty Images and Verizon to Award $20,000 Grant to Champion Disability Representation in the Workplace

Financing

Getty Images Holdings, Inc. Announces Comprehensive Refinancing of Approximately $1.042 Billion Existing Term Loans

Getty Images to Release Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025

Sports

Getty Images and UEFA Renew Multi-Year Agreement

Getty Images Signs Multi-Year Photography Partnership with the National Women's Soccer League

Getty Images Reports Fourth Quarter and Full Year 2024 Results

CLBR

NARI

NEUE

TURN

VINC

Angi

Bumble

Cars.com

Trump Media & Technology Group Corp. - Warrants

Trump Media & Technology

EverQuote

FuboTV

Nextdoor Holdings, Inc. Class A Common Stock

Nextdoor Holdings

MediaAlpha

Hello Group Inc. - American Depositary Shares

Hello Gr

Outbrain

QuinStreet

Shutterstock

Taboola.com

Tripadvisor

TrueCar

trivago N.V. - American Depositary Shares

trivago

Travelzoo

Vimeo

Vtex

WEBTOON Entertainment Inc. - Common stock

Webtoon Entertainment

Yalla Group Limited American Depositary Shares, each representing one Class A Ordinary Share

Yalla Group

Yelp

Ziff Davis

Zhihu Inc. American Depositary Shares, each representing three (3) Class A Ordinary Shares

Comments

Getty Images Holdings

Noticias

Últimas noticias sobre Getty Images Holdings (NYSE:GETY) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL